Ituran Location & Control Stock (NASDAQ: ITRN)

Ituran Location & Control Stock (NASDAQ:ITRN), Trade Ideas

Ituran Location & Control

Ituran Location and Control Ltd is a provider of location-based services. The company operates in two segments, namely Telematics services, and Telematics products. The Telematics services segment consists of regionally- based stolen vehicle recovery (SVR) services, fleet management services, and value-added services comprised of personal advanced locater services and concierge services. The Telematics product segment consists of short and medium-range two-way machine-to-machine wireless communications products that are used for various applications, including automatic vehicle location, and automatic vehicle identification. Its geographical segments include Israel, Brazil, and Others.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

ATXI

BALY

BIAF

BILI

BNED

CERO

EGOX

ELTK

GRPH

IMRN

ITRN

JFBR

LXEH

LXRX

MEDS

MESO

MNKD

MRAI

MRNA

MSTR

NBTX

NWTN

PLSE

PSTX

RVSN

SELX

SMCI

STAA

TCBP

VNET

VTYX

Shares of  Mesoblast Limited (NASDAQ: MESO) rose sharply during Monday’s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.

Mesoblast shares jumped 13.4% to $2.4399 on Monday.

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

AAOI

AFRM

APLM

ASST

AVXL

BDRX

BGLC

CAPT

CHWY

CLIR

HCWB

HUYA

INOD

IOBT

MIRA

OXBR

PERF

PUYI

RDHL

RELI

RILY

SBET

SHOT

SNES

Telecom Argentina Stet - France Telecom S.A.

THAR

VCXA

XENE

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) moved lower during Monday’s session after the company reported fourth-quarter financial results.

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

CAAP

GGAL

GLBE

ROKU

SHOP

TEVA

U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday.

Shares of Ituran Location and Control Ltd. (NASDAQ: ITRN) gained during Monday’s session after the company reported third-quarter financial results.

Ituran Location and Control Posts Q3 Results, Joins Crown Castle, Shopify And Other Big Stocks Moving Higher On Monday

Ituran Location and Control Ltd. - Ordinary Shares

Ituran Location and Control Ltd

Dividends

Ituran Location And Control Increases Dividend To 6%

Monday marks the last chance for investors to receive the next dividend payout from Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>). 
<h3>What's Happening</h3>
The company announced on Wednesday that it would pay shareholders a quarterly dividend of 39 cents per share. On Tuesday, Ituran Location &amp; Control will go ex-dividend, meaning the stock will trade lower to reflect that payout. In other words, the stock will likely open 39 cents lower than it would have opened on any other day.
In order to be eligible to receive a company's dividend, shareholders must own the stock prior to the ex-dividend date—in this case, Tuesday. Shareholders who own ITRN as of the end of Monday's session are eligible to receive the 39 cents dividend payout for every share that they own. 
According to the company, this dividend will be paid out to shareholders on April 03, 2024. Investors will then be able to either reinvest those dividends back into the stock or use the payment in some other way. 
To stay up-to-date with the companies that are announcing their dividends, <a href="https://www.benzinga.com/calendars/dividends">click here</a> to visit our Dividends Calendar.

Monday Is Your Last Chance To Buy Ituran Location & Control Before The Dividend Payout

Shares of Mesoblast Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meso#NASDAQ">MESO</a>) rose sharply during Monday&rsquo;s session after the company announced FDA support of an accelerated approval pathway for rexlemestrocel-L in end-stage heart failure patients.
Mesoblast shares jumped 13.4% to $2.4399 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>Kidpik Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pik#NASDAQ">PIK</a>) gained 238% to $9.15. Kidpik recently announced a 1-for 5 reverse stock split.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) shares surged 149% to $2.6450.</li>
<li>TRxADE HEALTH, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/meds#NASDAQ">MEDS</a>) gained 114.6% to $17.26. TRxADE Health recently announced a special cash dividend of $8 per share.</li>
<li>Fangdd Network Group Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/duo#NASDAQ">DUO</a>) shares climbed 108% to $1.2593 after the company announced its 2024 strategic layout with plans to enter the real estate stock asset services <a href="https://www.benzinga.com/money/best-sectors-to-invest-in-right-now/">sector</a>.</li>
<li>GDS Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/gds#NASDAQ">GDS</a>) shares gained 23.7% to $7.93 following a report suggesting Hillhouse and Boyu are in talks to invest in the company&#39;s Southeast Asia data center business.</li>
<li>Solidion Technology Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sti#NASDAQ">STI</a>) rose 23.3% to $0.9620.</li>
<li>Kingsoft Cloud Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/kc#NASDAQ">KC</a>) shares gained 23.1% to $3.31. Kingsoft Cloud is expected to report fourth-quarter financial results on March 20, 2024.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 21.7% to $13.89. EHang Holdings is expected to release its unaudited financial results for the fourth quarter on March 15, 2024.</li>
<li>Bally&#39;s Corporation (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/baly#NYSE">BALY</a>) gained 21.5% to $12.90. Standard General delivered a non-binding letter to the board of directors of Bally&#39;s proposing a transaction under which it would acquire all of the outstanding shares of common stock for $15/share, not currently owned by the company.</li>
<li>Rail Vision Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rvsn#NASDAQ">RVSN</a>) climbed 21.2% to $3.43. Rail Vision received an order from a Class 1 US railroad company for its AI-based safety system.</li>
<li>Marpai, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrai#NASDAQ">MRAI</a>) gained 18.7% to $2.0899.</li>
<li>bioAffinity Technologies, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/biaf#NASDAQ">BIAF</a>) climbed 18.3% to $1.81.</li>
<li>Lixiang Education Holding Co., Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxeh#NASDAQ">LXEH</a>) gained 15.6% to $4.8797.</li>
<li>Lexicon Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lxrx#NASDAQ">LXRX</a>) jumped 13.4% to $2.4650 after the company said it is preparing to resubmit its Sotagliflozin NDA for Type 1 diabetes following FDA feedback. Additionally, the company announced a securities purchase agreement expected to result in gross proceeds of around $250 million.</li>
<li>NWTN Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nwtn#NASDAQ">NWTN</a>) gained 13.4% to $4.8082.</li>
<li>Pulse Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/plse#NASDAQ">PLSE</a>) rose 12.7% to $10.86. Pulse Biosciences announced FDA 510(k) clearance for Cellfx NSPFA Percutaneous Electrode System.</li>
<li>Bilibili Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bili#NASDAQ">BILI</a>) gained 12.7% to $12.55 after JP Morgan upgraded the stock from Underweight to Neutral and raised its price target from $10 to $11. The stock is also gaining amid overall China strength following the annual National People&#39;s Congress event.</li>
<li>Graphite Bio, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/grph#NASDAQ">GRPH</a>) climbed 11.7% to $3.5080. Graphite Bio declared a special dividend in connection with proposed merger with Lenz Therapeutics.</li>
<li>STAAR Surgical Company (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/staa#NASDAQ">STAA</a>) jumped 10% to $39.45 after Stifel upgraded the stock from Hold to Buy and raised its price target from $30 to $50.</li>
<li>VNET Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vnet#NASDAQ">VNET</a>) rose 9.8% to $1.68.</li>
<li>Moderna, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mrna#NASDAQ">MRNA</a>) gained 9.2% to $112.51.</li>
<li>Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) climbed 7.8% to $28.42.</li>
<li>NuScale Power Corporation(NYSE: <a class="ticker" href="https://www.benzinga.com/stock/smr#NYSE">SMR</a>) gained 7% to $5.87. NuScale Power is expected to release fourth quarter results on March 14, 2024.</li>
<li>MicroStrategy Incorporated (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mstr#NASDAQ">MSTR</a>) gained 4.7% to $1,492.07 amid continued strength in Bitcoin.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>Jeffs&#39; Brands Ltd (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jfbr#NASDAQ">JFBR</a>) fell 45.2% to $0.8650.</li>
<li>Eltek Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eltk#NASDAQ">ELTK</a>) shares fell 20.9% to $11.00 after the company announced downbeat quarterly earnings.</li>
<li>CERo Therapeutics Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cero#NASDAQ">CERO</a>) declined 22% to $3.0822 after jumping 28% on Friday. CERo Therapeutics recently announced the publication of preclinical research analyzing CER-1236 in targeting Acute Myelogenous Leukemia tumor cells from human patients.</li>
<li>The Real Good Food Company, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rgf#NASDAQ">RGF</a>) fell 19.7% to $0.5536.</li>
<li>Ventyx Biosciences, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vtyx#NASDAQ">VTYX</a>) dipped 18.5% to $8.09. Ventyx Biosciences reported clinical data for its NLRP3 inhibitor portfolio and issued pipeline updates at Virtual Investor Event.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 15.3% to $6.78 after declining 8% on Friday. Lytus Technologies, last week, announced the launch of Lytus Cloud.</li>
<li>Next.e.GO N.V. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/egox#NASDAQ">EGOX</a>) declined 15.3% to $0.0727.</li>
<li>MoneyLion Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/ml#NYSE">ML</a>) fell 15% to $63.36.</li>
<li>Semilux International Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/selx#NASDAQ">SELX</a>) fell 14.8% to $1.4403 after jumping 69% on Friday.</li>
<li>Lytus Technologies Holdings PTV. Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/lyt#NASDAQ">LYT</a>) fell 14.6% to $6.83.</li>
<li>Barnes &amp; Noble Education, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/bned#NYSE">BNED</a>) dipped 13.8% to $0.7832. Barnes &amp; Noble Education recently rescheduled its third quarter fiscal year 2024 earnings release.</li>
<li>Psyence Biomedical Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pbm#NASDAQ">PBM</a>) fell 13.4% to $1.8272 after jumping 66% on Friday. The company recently announced its subsidiary, Psyence Australia, received Human Research Ethics Committee approval to initiate its Phase IIb study.</li>
<li>Immuron Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/imrn#NASDAQ">IMRN</a>) shares tumbled 12.5% to $3.3252 after dipping 16% on Friday.</li>
<li>Genie Energy Ltd. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/gne#NYSE">GNE</a>) fell 12% to $16.67 following fourth-quarter results.</li>
<li>Nanobiotix S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/nbtx#NASDAQ">NBTX</a>) dipped 9.8% to $6.35.</li>
<li>Avenue Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/atxi#NASDAQ">ATXI</a>) fell 8.9% to $0.1749 after surging 10% on Friday.</li>
<li>Super Micro Computer, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/smci#NASDAQ">SMCI</a>) dipped 8.8% to $1,039.60.</li>
<li>MannKind Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mnkd#NASDAQ">MNKD</a>) declined 8.7% to $4.81. MannKind announced initial meal challenge data from INHALE-3 Phase 4 U.S. trial comparing afrezza head-to-head with multiple daily injections and insulin pumps.</li>
<li>Poseida Therapeutics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pstx#NASDAQ">PSTX</a>) fell 8.1% to $3.74.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/03/37584162/wall-streets-most-accurate-analysts-say-buy-these-3-energy-stocks-with-over-3-dividend-y"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Energy Stocks With Over 3% Dividend Yields</a>

Why Mesoblast Shares Are Trading Higher By 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.60 per share which met the analyst consensus estimate. The company reported quarterly sales of $77.81 million which missed the analyst consensus estimate of $82.80 million by 6.03 percent. This is a 3.82 percent increase over sales of $74.95 million the same period last year.

Earnings

Earnings Misses

Ituran Location & Control Q4 2023 GAAP EPS $0.60, Inline, Sales $77.81M Miss $82.80M Estimate

ABUS

ACIC

ACIW

ADSK

AINC

AKLI

AMRN

AMWD

ANIP

ARGX

ARLO

AVPT

BBWI

BIRK

BLFS

BRFH

CAPR

CCOI

CDRO

CELH

CERT

CMPS

CMRX

COMM

CPSI

CRAI

CRDF

CRON

CUBE

CVEO

DAVA

DELL

DHIL

DMTK

DOLE

DOUG

ESAB

ESTC

EVLV

EVRG

EVRI

EXLS

FDUS

FIHL

FREY

FSCO

GDEN

GDRX

GECC

GLNG

GOLF

GOVX

GRBK

HAYW

HYFM

IHRT

INSW

INUV

JAKK

KPTI

LSEA

LSTA

Melco Resorts & Entertainment Limited - American Depositary Shares

MLCO

MNTX

MPLN

NBBK

Earnings Scheduled For February 29, 2024

Shares of Anavex Life Sciences Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/avxl#NASDAQ">AVXL</a>) moved lower during Monday&rsquo;s session after the company reported fourth-quarter financial results.
The company posted a quarterly net loss of $10.1 million, inclusive of $3.2 million in non-cash items, or 12 cents per share for the fourth quarter, versus a year-ago net loss of $14.3 million, inclusive of $6.0 million in non-cash items, or 18 cents per share for the year-ago period.
Anavex Life Sciences shares fell 10% to $6.35 on Monday.
Here are some other stocks moving in today&#39;s mid-day session.
<h3>Gainers</h3>
<ul>
<li>RedHill Biopharma Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rdhl#NASDAQ">RDHL</a>) shares climbed 125% to $0.7063 after the company announced the FDA has granted five years&#39; market exclusivity for Talicia.</li>
<li>Biodexa Pharmaceuticals Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bdrx#NASDAQ">BDRX</a>) gained 122.8% to $5.96 after the company announced it entered into agreements to acquire an exclusive worldwide license to tolimidone.</li>
<li>Tharimmune, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/thar#NASDAQ">THAR</a>) shares climbed 48.6% to $4.28 after the company reported Phase 1 data on TH104 for chronic pruritis in primary biliary cholangitis.</li>
<li>Asset Entities Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/asst#NASDAQ">ASST</a>) gained 34% to $0.4703 after the company announced a stock repurchase program.</li>
<li>Captivision Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/capt#NASDAQ">CAPT</a>) rose 20.1% to $2.81 after surging 44% on Friday.</li>
<li>Perfect Corp. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/perf#NYSE">PERF</a>) climbed 19.7% to $2.9944. The company on Monday announced the commencement of a tender offer to purchase shares above the current share price.</li>
<li>IO Biotech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/iobt#NASDAQ">IOBT</a>) gained 19% to $1.3988. IO Biotech Chief Accounting Officer Brian Burkavage acquired a total of 10,000 shares at an average price of $1.01.</li>
<li>TC Biopharm (Holdings) Plc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tcbp#NASDAQ">TCBP</a>) gained 18.4% to $0.6680 after the company announced FDA clearance of the Phase 1B IND for TCB-008 in Acute Myeloid Leukemia.</li>
<li>Apollomics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aplm#NASDAQ">APLM</a>) shares rose 18.3% to $1.1750 after surging 14% on Friday. The company&rsquo;s partner in China, Avistone Biotechnology Co. Ltd., recently received conditional approval from the National Medical Products Administration (NMPA) of China for the commercialization of vebreltinib to treat patients with MET exon 14 skipping non-small cell lung cancer (NSCLC).</li>
<li>Safety Shot, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/shot#NASDAQ">SHOT</a>) gained 17.8% to $4.2782.</li>
<li>ClearSign Technologies Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/clir#NASDAQ">CLIR</a>) gained 16% to $1.5665.</li>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) jumped 13.7% to $29.82 following reports of record &#39;buy now, pay later&#39; predictions on Cyber Monday.</li>
<li>MIRA Pharmaceuticals, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mira#NASDAQ">MIRA</a>) rose 13% to $3.72.</li>
<li>Oxbridge Re Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/oxbr#NASDAQ">OXBR</a>) gained 12.5% to $1.2156.</li>
<li>IRSA Inversiones y Representaciones Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irs#NYSE">IRS</a>) rose 12.4% to $9.13.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) gained 12.1% to $19.71.</li>
<li>Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) climbed 11.3% to $27.69 after the company reported third-quarter financial results.</li>
<li>Xenon Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xene#NASDAQ">XENE</a>) rose 10.2% to $31.93 after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) gained 8.8% to $14.19.</li>
<li>Telecom Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teo#NYSE">TEO</a>) rose 6.7% to $8.26.</li>
</ul>
<h3>Losers</h3>
<ul>
<li>10X Capital Venture Acquisition Corp. II (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/vcxa#NASDAQ">VCXA</a>) shares dipped 21.2% to $8.39.</li>
<li>BioNexus Gene Lab Corp. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/bglc#NASDAQ">BGLC</a>) fell 19.5% to $0.7246 after jumping 144% on Friday.</li>
<li>HCW Biologics Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hcwb#NASDAQ">HCWB</a>) declined 14.5% to $1.00.</li>
<li>SharpLink Gaming Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbet#NASDAQ">SBET</a>) fell 14.4% to $1.49.</li>
<li>Innodata Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/inod#NASDAQ">INOD</a>) fell 14.2% to $5.80.</li>
<li>Reliance Global Group, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/reli#NASDAQ">RELI</a>) declined 14% to $1.04.</li>
<li>SenesTech, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/snes#NASDAQ">SNES</a>) fell 13.6% to $1.8738.</li>
<li>B. Riley Financial, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/rily#NASDAQ">RILY</a>) dropped 11.2% to $18.61.</li>
<li>Puyi Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/puyi#NASDAQ">PUYI</a>) declined 10.8% to $3.53.</li>
<li>TMC the metals company Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/tmc#NASDAQ">TMC</a>) fell 10% to $1.2595.</li>
<li>HUYA Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/huya#NYSE">HUYA</a>) fell 7.4% to $3.5650.</li>
<li>Fisker Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/fsr#NYSE">FSR</a>) declined 6.7% to $2.08.</li>
<li>Chewy, Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/chwy#NYSE">CHWY</a>) fell 6.6% to $18.94.</li>
<li>Pagaya Technologies Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/pgy#NASDAQ">PGY</a>) fell 5.8% to $1.29 after the company said Michael Kurlander, Chief Financial Officer, has stepped down from his role to pursue an outside opportunity. The company named Deputy Chief Financial Officer Evangelos Perros as Interim Chief Financial Officer.</li>
<li>Polaris Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/pii#NYSE">PII</a>) fell 4% to $86.96.</li>
</ul>
Now Read This: <a href="https://www.benzinga.com/markets/cryptocurrency/23/11/35959301/bitcoin-falls-below-37-000-blur-gas-among-top-losers"> Bitcoin Falls Below $37,000; Blur, Gas Among Top Losers</a>

Why Anavex Life Sciences Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session

U.S. stocks traded mostly lower, with the Dow Jones falling around 50 points on Monday.
Shares of Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) gained during Monday&rsquo;s session after the company reported third-quarter financial results.
The company posted quarterly earnings of 63 cents per share, up from 49 cents per share in the year-ago period. The company&rsquo;s quarterly sales rose 12% to $81.05 million.
Ituran Location and Control shares gained 11.3% to $27.69 on Monday.
Here are some other big stocks recording gains in today&rsquo;s session.
<ul>
<li>Affirm Holdings, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/afrm#NASDAQ">AFRM</a>) surged 13.7% to $29.82 following reports of record &#39;buy now, pay later&#39; predictions on Cyber Monday.</li>
<li>IRSA Inversiones y Representaciones Sociedad An&oacute;nima (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/irs#NYSE">IRS</a>) shares jumped 12.4% to $9.13.</li>
<li>EHang Holdings Limited (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/eh#NASDAQ">EH</a>) rose 12.1% to $19.71.</li>
<li>Xenon Pharmaceuticals Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/xene#NASDAQ">XENE</a>) surged 10.2% to $31.93 after the company announced topline results from the Phase 2 proof-of-concept X-NOVA clinical trial of XEN1101 in MDD.</li>
<li>Applied Optoelectronics, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aaoi#NASDAQ">AAOI</a>) climbed 8.8% to $14.19.</li>
<li>Corporaci&oacute;n Am&eacute;rica Airports S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/caap#NYSE">CAAP</a>) rose 8.1% to $14.56.</li>
<li>Global-e Online Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/glbe#NASDAQ">GLBE</a>) climbed 7.4% to $33.95.</li>
<li>Telecom Argentina S.A. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teo#NYSE">TEO</a>) gained 6.7% to $8.26.</li>
<li>Grupo Financiero Galicia S.A. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ggal#NASDAQ">GGAL</a>) rose 6.7% to $16.35.</li>
<li>DRDGOLD Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/drd#NYSE">DRD</a>) gained 5.8% to $9.19.</li>
<li>Roku, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/roku#NASDAQ">ROKU</a>) rose 5.8% to $100.51.</li>
<li>Crown Castle Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/cci#NYSE">CCI</a>) rose 4.7% to $108.46 after activist fund Elliott took a $2 billion stake in the company and suggested operational improvements.</li>
<li>Teva Pharmaceutical Industries Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/teva#NYSE">TEVA</a>) gained 4.1% to $9.94 after UBS upgraded the stock from Neutral to Buy and raised its price target from $11 to $13.</li>
<li>Shopify Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/shop#NYSE">SHOP</a>) gained 4% to $73.20 after the company announced that Shopify merchants set a Black Friday record with a combined $4.1 billion in sales.</li>
</ul>
&nbsp;
Now Read This: <a href="https://www.benzinga.com/news/23/11/35955917/goldman-sachs-verisign-and-2-other-stocks-insiders-are-selling"> Goldman Sachs, VeriSign And 2 Other Stocks Insiders Are Selling</a>

WIIM

Ituran Location And Control shares are trading higher after the company reported Q3 financial results.

<h3>Companies Reporting Before The Bell</h3>
&bull; Smart Share Glb (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EM#NASDAQ">EM</a>) is projected to report earnings for its third quarter.
&bull; UP Fintech Holding (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TIGR#NASDAQ">TIGR</a>) is likely to report earnings for its third quarter.
&bull; Cerence (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRNC#NASDAQ">CRNC</a>) is expected to report earnings for its fourth quarter.
&bull; Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) is expected to report quarterly earnings at $0.58 per share on revenue of $82.10 million.
<h3>Companies Reporting After The Bell</h3>
&bull; Cango (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CANG#NYSE">CANG</a>) is expected to report earnings for its third quarter.
&bull; Zscaler (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZS#NASDAQ">ZS</a>) is estimated to report quarterly earnings at $0.49 per share on revenue of $474.31 million.
&bull; Grupo Supervielle (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SUPV#NYSE">SUPV</a>) is estimated to report earnings for its third quarter.
&bull; Seadrill (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SDRL#NYSE">SDRL</a>) is projected to report quarterly earnings at $0.66 per share on revenue of $408.00 million.
This article was generated by Benzinga&#39;s automated content engine and reviewed by an editor.

CANG

CRNC

SDRL

SUPV

TIGR

Earnings Scheduled For November 27, 2023

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported its Q3 earnings results on Monday, November 27, 2023 at 06:30 AM.
Here's what investors need to know about the announcement.
<h3>Earnings</h3>
Ituran Location &amp; Control beat estimated earnings by 8.62%, reporting an EPS of $0.63 versus an estimate of $0.58.
Revenue was up $8.39 million from the same period last year.
<h3>Past Earnings Performance</h3>
Last quarter the company missed on EPS by $0.1 which was followed by a 1.33% drop in the share price the next day.
Here's a look at Ituran Location &amp; Control's past performance:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.53</td>
<td>0.52</td>
<td>0.46</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.56</td>
<td>0.47</td>
<td>0.49</td>
</tr>
<tr>
<td>Revenue Estimate</td>
<td>80.90M</td>
<td>79.70M</td>
<td>74.60M</td>
<td>71.09M</td>
</tr>
<tr>
<td>Revenue Actual</td>
<td>81.64M</td>
<td>79.47M</td>
<td>74.95M</td>
<td>72.66M</td>
</tr>
</tbody>
</table>

To track all earnings releases for Ituran Location &amp; Control <a href="https://www.benzinga.com/quote/ITRN/earnings">visit their earnings calendar here.</a> 
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Ituran Location & Control: Q3 Earnings Insights

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) reported quarterly earnings of $0.63 per share. This is a 28.57 percent increase over earnings of $0.49 per share from the same period last year. The company reported quarterly sales of $81.05 million which missed the analyst consensus estimate of $82.10 million by 1.28 percent. This is a 11.54 percent increase over sales of $72.66 million the same period last year.

Ituran Location & Control Q3 EPS $0.63 Vs.  $0.49 Last Year, Sales $81.05M Miss $82.10M Estimate

With U.S. stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows:
<ul>
<li>Wall Street expects Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>) to report quarterly earnings at 49 cents per share on revenue of $476.74 million after the closing&nbsp;bell. Zscaler shares gained 1.3% to close at $193.09 on Friday.</li>
<li>Amazon.com Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) will remain in focus on Cyber Monday. The e-commerce giant&rsquo;s official Cyber Monday deals will run till Nov. 27. Amazon shares rose 0.02% to close at $146.74 on Friday.</li>
<li>Analysts expect Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) to earn 58 cents per share on revenue of $82.10 million for the latest quarter. The company will release earnings before the markets open. Ituran Location and Control shares gained 1.12% to close at $24.87 on Friday.</li>
</ul>
Check out our <a href="https://www.benzinga.com/premarket/"> premarket coverage here </a> 
<ul>
<li>Investors will keep an eye on Costco Wholesale Corp (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/cost#NASDAQ">COST</a>) today. Costco&rsquo;s Cyber Monday deals will be offered on Monday, Nov. 27, 2023. Costco shares gained 0.4% to close at $591.36 on Friday.</li>
<li>Target Corp (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/tgt#NYSE">TGT</a>) will also remain one of the major stocks to watch on Cyber Monday. The retailer is offering great deals on brands like Keurig, Corelle, Pyrex, Instant Pot, <a href="https://www.benzinga.com/markets/equities/23/11/35944138/cyber-monday-2023-sales-expected-to-hit-12b-amazon-walmart-costco-stocks-at-bargain-prices">Rubbermaid, Nespresso &amp; Crock Pot</a>. Target shares rose 0.7% to close at $131.46 on Friday.</li>
</ul>
Read This Next: <a href="https://www.benzinga.com/news/earnings/23/11/35935872/how-to-earn-500-a-month-from-deere-stock-following-upbeat-earnings"> How To Earn $500 A Month From Deere Stock Following Upbeat Earnings </a>

Pre-Market Outlook

AMZN

COST

Amazon, Zscaler And 3 Stocks To Watch Heading Into Monday

The CNN Money Fear and Greed index showed further improvement in overall market sentiment, with the index remaining in the &quot;Greed&quot; zone on Friday.
U.S. stocks closed mixed in the holiday-shortened trading session on Friday, ahead of the major shopping season. Meanwhile, all three major indices recorded their fourth straight weekly gains.
iRobot Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/irbt#NASDAQ">IRBT</a>) shares jumped around 39% following a report suggesting Amazon.com Inc.&rsquo;s (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) proposed acquisition of the robot vacuum maker is set to get unconditional approval from EU antitrust authorities.
On the economic data front, the S&amp;P Global U.S. services PMI rose to 50.8 in November from 50.6 in the previous month, recording the highest reading in four months and higher than market estimates of 50.4. The S&amp;P Global manufacturing PMI declined to 49.4 in November from 50 a month ago, and missing market expectations of 49.8.
U.S. stock markets were closed Thursday for the Thanksgiving holiday and closed early on Black Friday.
Most sectors on the S&amp;P 500 closed on a positive note, with healthcare and energy stocks recording the biggest gains on Friday. However, communication services and information technology stocks bucked the overall market trend, closing the session lower.
The Dow Jones closed higher by around 117 points to 35,390.15 on Friday. The S&amp;P 500 rose 0.06% at 4,559.34, while the Nasdaq Composite fell 0.11% at 14,250.85 during Friday&rsquo;s session.
Investors are awaiting earnings results from Zscaler, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/zs#NASDAQ">ZS</a>), Seadrill Limited (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/sdrl#NYSE">SDRL</a>), and Ituran Location and Control Ltd. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/itrn#NASDAQ">ITRN</a>) today.
At a current reading of 68.2, the index remained in the &quot;Greed&quot; zone on Friday, versus a prior reading of 66.8.
What is CNN Business Fear &amp; Greed Index?
The Fear &amp; Greed Index is a measure of the current market sentiment. It is based on the premise that higher fear exerts pressure on stock prices, while higher greed has the opposite effect. The index is calculated based on seven equal-weighted indicators. The index ranges from 0 to 100, where 0 represents maximum fear and 100 signals maximum greediness.
&nbsp;
Read Next: <a href="https://www.benzinga.com/trading-ideas/long-ideas/23/11/35939637/wall-streets-most-accurate-analysts-say-buy-these-3-financial-stocks-with-over-4-dividen"> Wall Street&#39;s Most Accurate Analysts Say Buy These 3 Financial Stocks With Over 4% Dividend Yields</a>

IRBT

Fear & Greed Index Remains In 'Greed' Zone; US Stocks Notch 4th Consecutive Weekly Gain

Ituran Location &amp; Control (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>) is set to give its latest quarterly earnings report on Monday, 2023-11-27. Here's what investors need to know before the announcement.
Analysts estimate that Ituran Location &amp; Control will report an earnings per share (EPS) of $0.58. 
Ituran Location &amp; Control bulls will hope to hear the company announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.
New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).
<h3>Historical Earnings Performance</h3>
Last quarter the company missed EPS by $0.10, which was followed by a 1.33% drop in the share price the next day.
Here's a look at Ituran Location &amp; Control's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q2 2023</th>
<th>Q1 2023</th>
<th>Q4 2022</th>
<th>Q3 2022</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>0.53</td>
<td>0.53</td>
<td>0.52</td>
<td>0.46</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>0.43</td>
<td>0.56</td>
<td>0.47</td>
<td>0.49</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-1.33%</td>
<td>-1.81%</td>
<td>1.88%</td>
<td>1.32%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2023/1700834421_0.png" alt="eps graph" />
<h3>Stock Performance</h3>
Shares of Ituran Location &amp; Control were trading at $24.58 as of November 21. Over the last 52-week period, shares are up 5.72%. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. 
<a href="https://www.benzinga.com/quote/ITRN/earnings">To track all earnings releases for Ituran Location &amp; Control visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Preview: Ituran Location & Control's Earnings

As global markets brace for the geopolitical upheaval stemming from the Israel-Hamas conflict, prominent investor Cathie Wood finds her ARK Israel Innovative Technology ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/IZRL#NYSE">IZRL</a>) thrust into the <a href="https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35144783/goldman-sachs-bullish-on-crude-oil-with-israel-hamas-at-war-brent-seen-rising-above">forefront of market dynamics. </a>
While often overshadowed by its larger counterparts, such as the ARK Innovation ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ARKK#NYSE">ARKK</a>), the smallest ARK fund with only $99 million of asset under management is now under intense scrutiny as investors closely monitor its holdings in the midst of escalating Middle East tensions.
<h2 class="wp-block-heading">Volatility Surrounds Cathie Wood&#8217;s ARK Israel Innovative Technology ETF</h2>
As the trading week commenced, the ARK Israel Innovative Technology ETF faced an immediate test, dropping by 5%, underscoring the heightened sensitivity of the fund to geopolitical events in the region. If this negative performance persists throughout the close, it would represent the fund&#8217;s most challenging session since mid-June 2022.
Chart: ARK Israel Innovative Technology ETF Tumbled 5% At The Opening Bell In New York
<figure class="wp-block-image size-large"><img decoding="async" loading="lazy" width="1024" height="730" src="https://s3.amazonaws.com/editorial.benzinga.com/wp-content/uploads/2023/10/09094200/IZRL_2023-10-09_14-41-37_cc374-1024x730.png" alt="" class="wp-image-120600" srcset="https://s3.amazonaws.com/editorial.benzinga.com/wp-content/uploads/2023/10/09094200/IZRL_2023-10-09_14-41-37_cc374-1024x730.png 1024w,https://s3.amazonaws.com/editorial.benzinga.com/wp-content/uploads/2023/10/09094200/IZRL_2023-10-09_14-41-37_cc374-300x214.png 300w,https://s3.amazonaws.com/editorial.benzinga.com/wp-content/uploads/2023/10/09094200/IZRL_2023-10-09_14-41-37_cc374-768x547.png 768w,https://s3.amazonaws.com/editorial.benzinga.com/wp-content/uploads/2023/10/09094200/IZRL_2023-10-09_14-41-37_cc374.png 1515w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
The fund boasts a diversified portfolio of 76 companies, with a predominant presence in the technology sector, constituting 53% of its holdings. Notably, the software industry commands the lion&#8217;s share at 25%, closely followed by communication equipment at 11%.
ARK Investment Management introduced the ARK Israel Innovative Technology ETF in December 2017 to trace the price movements of publicly-listed Israeli companies renowned for pioneering disruptive technologies across sectors such as genomics, healthcare, biotechnology, industrials, manufacturing, the Internet, and information technology.
While the ARK Israel Innovative Technology ETF reports flat year-to-date performance, it has experienced a notable 14% decline from its zenith in May 2023. The fund&#8217;s performance since inception mirrors this negative trajectory, currently standing at a negative 14%. Its standout period occurred between March 2020 and February 2021 when it delivered a remarkable 175% performance gain.
Read also: <a href="https://www.benzinga.com/markets/equities/23/10/35143020/s-p-500-nasdaq-set-for-bleak-start-to-week-as-middle-east-tensions-dampen-risk-on-mood-earnings-">S&amp;P 500, Nasdaq Set For Bleak Start To Week As Middle East Tensions Dampen Risk-On Mood: Earnings, Inflation Data In Focus</a>
<h2 class="wp-block-heading">10 Israeli Stocks To Watch Amid Geopolitical Turmoil</h2>
As the uncertainty in the Middle East unfolds, a handful of stocks within the ARK Israel Innovative Tech ETF have garnered attention due to their potential significance in navigating the fund through these turbulent times. Here are 10 noteworthy stocks that investors should closely monitor:
<figure class="wp-block-table"> 
<table>
<thead>
<tr>
<th>Company</th>
<th>Ticker</th>
<th>Sector</th>
<th>Shares</th>
<th>Market Value ($)</th>
<th>Weight (%)</th>
<th>Performance YTD</th>
</tr>
</thead>
<tbody>
<tr>
<td>CAMTEK LTD</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAMT#NASDAQ">CAMT</a>)</td>
<td>Information Technology</td>
<td>50,392</td>
<td>$3,191,325.36</td>
<td>3.43%</td>
<td>185%</td>
</tr>
<tr>
<td>UROGEN PHARMA LTD</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/URGN#NASDAQ">URGN</a>)</td>
<td>Healthcare</td>
<td>215,272</td>
<td>$2,949,226.40</td>
<td>3.17%</td>
<td>55%</td>
</tr>
<tr>
<td>TABOOLA.COM LTD</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBLA#NASDAQ">TBLA</a>)</td>
<td>Information Technology</td>
<td>672,718</td>
<td>$2,737,962.26</td>
<td>2.94%</td>
<td>32%</td>
</tr>
<tr>
<td>TEVA PHARMACEUTICAL-SP ADR</td>
<td>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TEVA#NYSE">TEVA</a>)</td>
<td>Healthcare</td>
<td>254,810</td>
<td>$2,400,310.20</td>
<td>2.58%</td>
<td>3%</td>
</tr>
<tr>
<td>CYBERARK SOFTWARE LTD</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYBR#NASDAQ">CYBR</a>)</td>
<td>Information Technology</td>
<td>14,063</td>
<td>$2,351,192.97</td>
<td>2.52%</td>
<td>29%</td>
</tr>
<tr>
<td>ITURAN LOCATION AND CONTROL LTD.</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ITRN#NASDAQ">ITRN</a>)</td>
<td>Information Technology</td>
<td>79,608</td>
<td>$2,329,330.08</td>
<td>2.50%</td>
<td>41%</td>
</tr>
<tr>
<td>CHECK POINT SOFTWARE TECH LTD</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHKP#NASDAQ">CHKP</a>)</td>
<td>Information Technology</td>
<td>16,962</td>
<td>$2,324,133.24</td>
<td>2.49%</td>
<td>9%</td>
</tr>
<tr>
<td>WIX.COM LTD</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WIX#NASDAQ">WIX</a>)</td>
<td>Information Technology</td>
<td>25,543</td>
<td>$2,307,043.76</td>
<td>2.48%</td>
<td>18%</td>
</tr>
<tr>
<td>SAPIENS INTERNATIONAL CORP N.V.</td>
<td>(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPNS#NASDAQ">SPNS</a>)</td>
<td>Information Technology</td>
<td>78,880</td>
<td>$2,270,166.40</td>
<td>2.44%</td>
<td>59%</td>
</tr>
<tr>
<td>HILAN LTD</td>
<td>(OTCPK: HLTEF)</td>
<td>Industrials</td>
<td>43,918</td>
<td>$2,256,421.42</td>
<td>2.42%</td>
<td>9.4%</td>
</tr>
</tbody>
</table>
</figure>
Now Read: <a href="https://www.benzinga.com/news/23/10/35138138/how-the-israel-hamas-conflict-could-impact-oil-markets">How The Israel-Hamas Conflict Could Impact Oil Markets</a>
Photo: Shutterstock

Biotech

Mid Cap

Sector ETFs

Specialty ETFs

Health Care

Emerging Market ETFs

Economics

Startups

Tech

ETFs

ARKK

CAMT

Cathie Wood's ARK Israel Innovative Tech ETF Braces For Impact Amid Regional Warfare: 10 Stocks To Watch